Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress

EHA 2025: Ellagic Acid Shown to Protect Against Iron-Induced Liver Injury

Award-winning research presented by Hangjie Fu at EHA shows that ellagic acid can protect against iron overload-induced liver injury by modulating ferroptosis and the TGFβ/Smad pathway, offering new therapeutic potential for iron-related complications in haematological disorders.

EHA 2025: Top 5 Takeaways for Hematologic Malignancy Management

Data from the 2025 EHA Congress show developments in novel therapeutic strategies across different multiple myeloma, leukemia, and lymphoma populations.

Attending a hematology conference as a sickle cell patient is...

Columnist Mary Shaniqua shares the benefits of attending the European Hematology Association's 2025 Congress as a sickle cell patient.

GeoVax Highlights Positive Immune Response Results From GEO-CM04S1 in CLL Patients at the European Hematology Association 2025 Meeting

Open the article to view the coverage from NewMediaWire

Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress

At the 30th European Hematology Association (EHA) Congress, hematology experts highlight breakthroughs in treatment, the importance of patient voices, and challenges in making innovations accessible worldwide.